NDC 85509-1032-01 - Omeprazole and Sodium Bicarbonate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85509-1032
- Requested NDC
- 85509-1032-01
- Package NDCs from labels
- 85509-1032-1, 85509-1032-3, 85509-1032-6, 85509-1032-01
- Manufacturer
- PHOENIX RX LLC
- Effective date
- 2025-07-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Omeprazole and Sodium Bicarbonate - PHOENIX RX LLC | PHOENIX RX LLC | 2025-07-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85509-1032-1 | Omeprazole and Sodium Bicarbonate | 15 in 1 BOTTLE | CAPSULE | 15 | 1 | |
| 85509-1032-3 | Omeprazole and Sodium Bicarbonate | 30 in 1 BOTTLE | CAPSULE | 30 | 1 | |
| 85509-1032-6 | Omeprazole and Sodium Bicarbonate | 60 in 1 BOTTLE | CAPSULE | 60 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 85509-1032-1 | EA - Each | 85509-1032 | 4c44b5b7-b0ac-484d-85f9-a17e3036fe01 | 1 | 2025-09-12 |
| 85509-1032-3 | EA - Each | 85509-1032 | 5b2a135a-edb3-4cde-a451-100ae6c39f73 | 1 | 2025-09-12 |
| 85509-1032-6 | EA - Each | 85509-1032 | 73130392-c1c3-4357-9318-162a7e2bbbf8 | 1 | 2025-09-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Omeprazole | OMEPRAZOLE | A-S Medication Solutions | c1276463-7357-45b5-9f7e-8d3c4a550ff4 | 2026-03-18 | Warnings, Adverse reactions | KG60484QX9 |
| Omeprazole | OMEPRAZOLE | A-S Medication Solutions | df1a4294-3893-4a11-b4d5-f3536678087e | 2026-03-18 | Warnings, Adverse reactions | KG60484QX9 |
| omeprazole | OMEPRAZOLE | Little Pharma, Inc. | d4f86bbe-fe4d-41e2-96cc-4b4bbe2f1f7f | 2026-03-16 | Warnings | KG60484QX9 |
| equate omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | WALMART INC. | c24c3326-99da-4c7d-aecc-7b4a8ac3f04e | 2026-03-15 | Warnings | 616539 KG60484QX9 8MDF5V39QO |
| Omeprazole DR | OMEPRAZOLE | Advanced Rx Pharmacy of Tennessee, LLC | c8bf92c9-1bab-7985-e053-2995a90a0225 | 2026-03-13 | Warnings, Adverse reactions | KG60484QX9 |
| Leader Ultra Lubricating Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Cardinal Health | d7f011a2-05ba-47c3-9519-d31602e105c7 | 2026-03-12 | Warnings | 6DC9Q167V3 |
| Leader Restorative Formula Lubricant Eye Drops | PROPYLENE GLYCOL | Cardinal Health | 87fef7e4-e5a8-4aad-94d2-f80f34826d97 | 2026-03-12 | Warnings | 6DC9Q167V3 |
| Omeprazole | OMEPRAZOLE | NuCare Pharmaceuticals,Inc. | af707c0a-5193-3f83-e053-2995a90a78ef | 2026-03-11 | Warnings, Adverse reactions | KG60484QX9 |
| Omeprazole | OMEPRAZOLE | NuCare Pharmaceuticals,Inc. | e07af8c9-559c-5a93-e053-2a95a90a2c63 | 2026-03-11 | Warnings, Adverse reactions | KG60484QX9 |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Hospira, Inc. | 084f5572-8c1f-4802-b179-ca0cc838fc68 | 2026-03-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | 0c24b592-4bc8-456f-acac-9c9525844a06 | 2026-03-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| Omeprazole | OMEPRAZOLE | Dr. Reddy's Laboratories Limited | 603d2d06-c5e8-4378-a422-8dca1a410af7 | 2026-03-02 | Warnings, Adverse reactions | KG60484QX9 |
| Omeprazole | OMEPRAZOLE | NorthStar Rx LLC | 40a75dc7-49b7-5c9d-6c5f-d4682ec6922e | 2026-03-02 | Warnings, Adverse reactions | KG60484QX9 |
| Sodium Bicarbonate 5 gr | SODIUM BICARBONATE | TWIN MED LLC | 12cad432-99db-4a9b-8619-82794e29409e | 2026-03-01 | Warnings | 8MDF5V39QO |
| Leader Extra Strength Effervescent Antacid and Pain Reliever | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Cardinal Health | c5d7bf5f-3e59-52f2-e053-2a95a90a4a00 | 2026-02-25 | Warnings | 8MDF5V39QO |
| Droptics Performance Eye Drops | NAPHAZOLINE HYDROCHLORIDE, PROPYLENE GLYCOL | Droptics LLC | 20fd6822-a7fd-4593-92bb-0a07260893e2 | 2026-02-09 | Warnings | 6DC9Q167V3 |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Amneal Pharmaceuticals Private Limited | ba92f45a-0187-4709-aa70-462b8dae09e9 | 2026-02-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| omeprazole | OMEPRAZOLE | HyVee Inc | a5df7dac-00f4-4d97-9586-cde3055890ac | 2026-02-04 | Warnings | KG60484QX9 |
| omeprazole | OMEPRAZOLE | HyVee Inc | fd22d4df-9679-4c2d-9bc4-3619288fb4cc | 2026-02-01 | Warnings | KG60484QX9 |
| omeprazole | OMEPRAZOLE | HyVee Inc | cf9919e6-a839-4bad-a007-80d5bf6f81db | 2026-01-30 | Warnings | KG60484QX9 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.